PURE Bioscience, Inc. (PURE) Gross margin 2019–2025
PURE Bioscience, Inc. (PURE) gross margin by fiscal year — reported gross profit divided by reported revenue.
59.2%FY2025 · since FY2019: 61.9% → 59.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 59.2% | +0.5 pp |
| FY2024 | 58.7% | +7.0 pp |
| FY2023 | 51.7% | -2.2 pp |
| FY2022 | 54.0% | +1.1 pp |
| FY2021 | 52.8% | -5.3 pp |
| FY2020 | 58.1% | -3.7 pp |
| FY2019 | 61.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice